Henan Taloph Pharmaceutical Stock Co.,Ltd (SHA:600222)

Revenue by Product

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Pharmaceutical Manufacturing	1.65B
Pharmaceutical Manufacturing Growth	8.53%
Drug Research and Development	343.40M
Drug Research and Development Growth	6.77%
Circulation of Medicines and Medicinal Materials	142.42M
Circulation of Medicines and Medicinal Materials Growth	-4.98%
Inter-segment Elimination	-76.97M
Inter-segment Elimination Growth	39.97%
Other	6.77M
Other Growth	-66.02%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
China	2.07B
China Growth	5.57%